Informa

第三天 -

第三天 -

search
8:00am - 8:10am
報名・咖啡時光
主題演講
Showing 1 of 1 Streams
8:10am - 8:15am
主席致詞
8:15am - 8:45am
用編碼mRNA的干擾素lambda調節呼吸道中的宿主免疫力
  • Christian Plank, PhD - Chief Technology Officer, Ethris GmbH
8:45am - 9:15am
mRNA 分析策略
  • Simon Klenk, PhD - Director RNA Analytics, RNA Biochemistry, BioNTech SE
9:15am - 9:45am
針對每個 mRNA 序列微調基於 PCR 的 mRNA 製造平台
  • Aditi Mehta, PhD - Associate Director, Head of mRNA Process & Deliver, Merck KGaA
9:45am - 10:15am
實現基於 mRNA 療法臨床開發的脂質奈米粒子
  • Ying Tam, Ph.D. - Chief Scientific Officer, Acuitas Therapeutics
10:15am - 10:55am
交流/咖啡時光、觀賞海報和展覽
同期會議主題
Showing 2 of 2 Streams
10:55am - 11:00am
主席致詞
11:00am - 11:30am
STK-002 的臨床前數據，一種正在開發用於治療常染色體顯性視神經萎縮 (ADOA) 的反義寡核甘酸
  • Shobha Ravipaty, PhD - Director, Stoke Therapeutics
11:30am - 12:00pm
寡核甘酸療法的發現與遞送
  • Jayaprakash Nair, PhD - Vice President, Research, Chemistry and Delivery Science, Alnylam Pharmaceuticals
12:00pm - 12:30pm
從實驗室到臨床：開發用於難治性癌症患者免疫治療的 GalXC-Plus siRNA 和 DCR-STAT3
  • Jennifer Lockridge, PhD - VP, Dicerna TRU Early Development, Novo Nordisk
10:55am - 11:00am
主席致詞
11:00am - 11:30am
用於穿越血腦屏障遞送治療性 RNA 之以蛋白質為基礎的奈米膠囊
  • Ekkehard Leberer, PhD - Scientific Advisor, Neuway Pharma
11:30am - 12:00pm
利用組織標靶脂質奈米粒子 (ttLNP) 平台重新定義新型基因組藥物的非病毒遞送
  • Kate Zhang, Ph.D. - Chief Scientific Officer, Hopewell Therapeutics
12:00pm - 12:30pm
調整脂質奈米粒子以適應特定應用
  • Ed Yaworski - Chief Technology Officer, Genevant Sciences Corp
12:30pm - 1:40pm
交流・午餐會、觀賞海報和展覽
Showing 2 of 2 Streams
1:40pm - 1:45pm
主席致詞
1:45pm - 2:15pm
用於治療癌症的標靶免疫抑制腫瘤微環境之反義寡核甘酸案例
  • Frank Jaschinski, Ph.D. - Chief Scientific Officer, Secarna Pharmaceuticals
2:15pm - 2:45pm
CIVI 008：一種針對 PCSK9 的口服活性 LNA 藥物
  • Henrik Oerum, PhD - Founder and Chief Scientific Officer, CiVi Biopharma Inc.
2:45pm - 3:15pm
TTX-MC138 的開發，一種針對多原發轉移癌的首創 miRNA-10b 標靶療法
  • Zdravka Medarova, PhD - Founder and Chief Technology Officer, TransCode Therapeutics
1:40pm - 1:45pm
主席致詞
1:45pm - 2:15pm
Gate2Brain Shuttles：除了運輸小分子之外的作用
  • Meritxell Teixido, PhD - CEO and CSO, Gate2Brain
2:15pm - 2:45pm
為高效、安全的大規模胜肽生產製程制定控制策略
  • El Djouhar Rekai, PhD - Head of Peptide Process Development & Manufacturing, PolyPeptide Group
2:45pm - 3:15pm
胜肽/核甘酸合成中整合流動化學的線上監測方法
  • Pengyu Xu, Ph.D. - President and Representative Director, SynCrest Inc.
3:15pm - 3:45pm
交流/咖啡時光、觀賞海報和展覽
Showing 2 of 2 Streams
3:45pm - 4:15pm
使用含有 PN 的嵌合寡核甘酸在臨床前模型中為患有杜氏肌肉營養不良症的男孩創建外顯子跳躍療法
  • Elizabeth Wagner, Ph.D. - Director, Biology, Wave Life Sciences
4:15pm - 4:45pm
IND 申請中精心設計的非臨床部分的構成要素
  • Emily Place, PhD - Senior Consultant Nonclinical, Biologics Consulting
4:45pm - 5:15pm
GalAhead™：下調單一/多個基因的 RNAi 治療平台
  • Jimmy Weterings, PhD - Senior Director, Head of Technology Development, Sirnaomics
3:45pm - 4:15pm
胜肽CMC策略
  • Stephane Varray, PhD - Director, Global Peptides Platform, CordenPharma International
4:15pm - 4:45pm
綠色生產胺基酸的生物催化劑
  • Christina Boville, PhD - Co-founder & CEO, Aralez Bio
4:45pm - 5:15pm
個體化癌症疫苗：發展高通量 cGMP 生產概念
  • Alaric Desmarchelier, PhD - Business Development Manager - Peptides, Almac Group
5:15pm - 5:20pm
會議結束
第二天

* 活動內容有可能不事先告知作更動及調整。